Senior Director, Global Program Lead (Cell Therapy), Oncology Therapeutic Area
Current
Dec 2023 - Present
AeroLeads people directory · profile
Michael Curley Email & Phone Number
Senior Director, Global Program Lead (Cell Therapy), Oncology Therapeutic Area
at
Takeda Oncology
1 work email found
@millennium.com
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
Senior Director, Global Program Lead (Cell Therapy), Oncology Therapeutic Area
Location
Cambridge, Massachusetts, United States
Who is Michael Curley? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Curley is listed as Senior Director, Global Program Lead (Cell Therapy), Oncology Therapeutic Area at Takeda Oncology, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at millennium.com and a matched LinkedIn profile for Michael Curley.
Michael Curley previously worked as Sr. Director, Cell Therapy Innovation at Takeda at Takeda Oncology and Director, Cell Therapy Innovation at Takeda Oncology at Takeda Oncology. Michael Curley holds Phd, Biochemistry from University Of Galway.
Company email context
Email format at Takeda Oncology
This section adds company-level context without repeating Michael Curley's masked contact details.
{first}.{last}@millennium.com
86% confidence
AeroLeads found 1 current-domain work email signal for Michael Curley. Compare company email patterns before reaching out.
Profile bio
About Michael Curley
Strategic team leader with 14 years of experience in drug discovery, development and clinical testing, and a strong track record of advancing programs from target ID through key milestones to the clinic. Adept in building, mentoring, and managing high-performing, cross-functional teams. Drive program strategy and prioritization, and manage collaborations, business development and timelines. Collaborative, well-organized and versatile in fast-paced environments, with proven ability to address and navigate strategic challenges, effectively prioritize work and harness multi-disciplinary expertise to achieve goals in a timely and professional manner.
Listed skills include Western Blotting, Flow Cytometry, Cancer Biology, Elisa, and 24 others.
Current workplace
Michael Curley's current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles
Michael Curley work experience
A career timeline built from the work history available for this profile.
Sr. Director, Cell Therapy Innovation At Takeda
Responsible for Discovery strategy, oversight, and advancement of allogeneic cord blood NK (CBNK) cell therapy platform. Set near-term goals and long-term vision for internal CBNK pipeline programs.• Led Takeda’s first internal end-to-end CBNK pipeline program from project start (PS) to candidate selection (CS), overseeing construct design & optimization, identifying and addressing program gaps, and directing execution of in vitro and in vivo POC studies to support advancement as a Development candidate• Direct internal CBNK program leads in generating concise, stage-appropriate data packages that inform on key MOA and support program Go/No-Go decisions at critical milestones in a timely manner• Research lead on two Global Program Teams for CBNK assets (one in Phase 1 clinical testing and the other advancing to an IND filing), ensuring appropriate non-clinical data is generated to support proposed MOA and near/long-term clinical development plans (e.g., synergistic combination agent prioritization, optimal dosing strategies) • Research lead for Heme Disease Area Strategy group, tasked with defining optimal ‘white spaces’ within heme indications to target based on patient unmet need and asset target product profiles• Responsible for crafting and authoring Pharmacology section of two cell therapy IND filings• Serve as CBNK platform liaison for external collaborations• Support business development and external innovation functions in search and evaluation of potential partners and/or novel technologies aligned with current strategic mandate• Recognized with “Takeda Exceptional Leadership Award” in 2020
Nov 2022 - Nov 2023
Director, Cell Therapy Innovation At Takeda Oncology
Mar 2021 - Nov 2022
Associate Director, I-O Biology
Led early Discovery programs on the Attenukine™ platform, an antibody – attenuated interferon alpha fusion protein, in collaboration with TEVA Pharmaceuticals• Discovery lead on clinical team for modakafusp alfa (moda), an anti-CD38 Attenukine™, leading preclinical efforts towards defining key mechanism of action (MOA) and optimal clinical combination strategies for moda, as well as presenting to external stakeholders and KOLs• JSC member on external collaborations with Crescendo Biologics and TEVA Pharmaceuticals
Feb 2019 - Mar 2021
Senior Scientist Ii, I-O Biology
Jan 2017 - Feb 2019
Associate Director, Mm-141 Research
Established strategic priorities and led a non-clinical/translational team in generating data packages to guide clinical development of MM-141, a novel bispecific antibody targeting IGF-1R and ErbB3• Led translational team (6 reports) that robustly characterized the activity and MOA of MM-141 and identified optimal combination agents for clinical testing • Designed and implemented in vivo biomarker and pharmacodynamic strategies to enable MM-141 Phase 1 (multiple indications) and Phase 2 (metastatic pancreatic cancer) studies, and incorporated these contributions into study materials (i.e., clinical protocol, investigator brochure, lab manual) • Lead author on successful FDA application for orphan drug designation for MM-141 in pancreatic cancer in the United States• Advanced clinical opportunities for MM-141 through the formation of external collaborations and research agreements with academic institutions/CROs• Presented pre-clinical research findings/strategy and early clinical data to senior leadership, scientific advisory boards, clinical investigators, and external audiences for business development purposes
Aug 2016 - Oct 2016
Principal Scientist & Research Team Leader, Mm-141
Jun 2014 - Jul 2016
Senior Scientist
Spearheaded multiple pre-clinical research efforts to generate data packages to support the clinical development of MM-121, an anti-ErbB3 antibody, for multiple Phase 2 trials.• Delivered oral presentation at AACR and composed a manuscript (Curley et al. MCT, 2015) characterizing the activity of MM-121 in combination with an aromatase inhibitor in a preclinical model of post-menopausal breast cancer in collaboration with academic investigators
Sep 2010 - Jun 2014
Post-Doctoral Fellow
• Optimized patient-derived xenograft mouse model of primary human ovarian tumors, which led to the identification and characterization of CD133 as a marker of ovarian tumor-initiating cells using multi-parameter flow cytometry (Curley et al. Stem Cells, 2009)
Oct 2006 - Sep 2010
Post-Doctoral Fellow
Nov 2004 - Sep 2006
2 education records
Michael Curley education
Phd, Biochemistry
University Of Galway
B.S., Biotechnology
University Of Galway
FAQ
Frequently asked questions about Michael Curley
Quick answers generated from the profile data available on this page.
What company does Michael Curley work for?
Michael Curley works for Takeda Oncology.
What is Michael Curley's role at Takeda Oncology?
Michael Curley is listed as Senior Director, Global Program Lead (Cell Therapy), Oncology Therapeutic Area at Takeda Oncology.
What is Michael Curley's email address?
AeroLeads has found 1 work email signal at @millennium.com for Michael Curley at Takeda Oncology.
Where is Michael Curley based?
Michael Curley is based in Cambridge, Massachusetts, United States while working with Takeda Oncology.
What companies has Michael Curley worked for?
Michael Curley has worked for Takeda Oncology, Merrimack Pharmaceuticals, Massachusetts General Hospital, and Joslin Diabetes Center.
How can I contact Michael Curley?
You can use AeroLeads to view verified contact signals for Michael Curley at Takeda Oncology, including work email, phone, and LinkedIn data when available.
What schools did Michael Curley attend?
Michael Curley holds Phd, Biochemistry from University Of Galway.
What skills is Michael Curley known for?
Michael Curley is listed with skills including Western Blotting, Flow Cytometry, Cancer Biology, Elisa, Molecular Biology, Translational Research, Cell Signaling, and Immunohistochemistry.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial